The Deputy Lab Manager will play a crucial role managing a team of Biomedical Scientists (BMS) and Medical Laboratory Assistants (MLA) within the Cyted UK laboratory. The role holder will report to the Laboratory Manager, as well as deputising for the Laboratory Manager where needed. The Deputy Laboratory Manager will perform routine analytical testing on a range of biological samples. They will be responsible for processing patient samples in good time and will ensure that service standards for reporting results are achieved. The Deputy Laboratory Manager will be expected to prioritise their own workload and manage the workload of the BMSs and MLAs in their team as well as perform urgent analytical testing as required. They will also supervise, train and support staff in their team. The role holder will be expected to support the Lab Manager and Quality Manager to maintain the highest standards of laboratory practice in line with HCPC and ISO 15189 policies.
Working Pattern and Location
The role is a full-time position with a standard 37.5 hour working week. The role holder may be required to work flexibly.
The role will be based at the Cyted’s Laboratory 2 Falcon Road, Hinchingbrooke Business Park, Huntingdon, Cambridgeshire, United Kingdom, PE29 6FG.
The role holder may need to visit other company sites when and if required.
Cyted is on a mission to build a world where disease is prevented rather than treated. We focus on providing innovative diagnostic technologies to drive the earlier detection of disease in the gastrointestinal tract, first focused on oesophageal cancer (and its precursor Barrett’s Oesophagus) with a non-endoscopic, minimally-invasive test.
Headquartered in Cambridge, we are at the forefront of developing cutting-edge diagnostic technologies that enable better access to care for patients at risk or early and advanced disease. Leveraging expertise in GI and, biomarker discovery, we are focussed on improving patient outcomes by detecting gastrointestinal cancer and inflammatory disease when it is more easily treated.
Our core product is the minimally invasive EndoSign test. The test is a combination of a simple device coupled with laboratory biomarkers to detect oesophageal cancer and its precursor Barrett’s Oesophagus. The test sees patients swallow a capsule attached to a strong, thin thread. The capsule dissolves in the stomach, releasing the sponge. This is then gently pulled back out, collecting cells from the entire length of the oesophagus. The collection of cells using the EndoSign cell collection device is a simple, minimally invasive procedure that can be carried out within 10 minutes and has significant benefits over the alternative procedures currently offered in healthcare settings. To find out more about the EndoSign test please see HERE. To date, we have tested over 16,000 patients across the UK in over 60 NHS Trusts and 10 community-based clinics in GPs and Community Diagnostic Centres. We process the samples in our fully digital laboratory and leverage AI to optimise reporting of the pathology results
We are committed to inclusion and diversity and believe that having a team that reflects a broad range of experiences and perspectives will help deliver diagnostic solutions for our customers that lead to the best outcomes for patients. We especially encourage applications from people who are underrepresented in the population and/or who have non-traditional education or career experiences.
We interview on a rolling basis, starting with a brief call to discuss what we're doing and whether it resonated with you.